Adult Liposarcoma

9 registered clinical trials studyying Adult Liposarcoma.

Status	Trial	Sponsor	Phase
Completed	Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone NCT02357810	Northwestern University	Phase 2
Completed	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma NCT01532687	OHSU Knight Cancer Institute	Phase 2
Completed	Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Ca NCT01477021	Fred Hutchinson Cancer Center	Phase 1
Completed	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174	National Cancer Institute (NCI)	Phase 1
Completed	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma NCT00659360	National Cancer Institute (NCI)	Phase 2
Completed	Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft NCT00346164	Children's Oncology Group	Phase 3
Terminated	Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma NCT00233948	City of Hope Medical Center	Phase 1 / Phase 2
Completed	Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma NCT00112463	National Cancer Institute (NCI)	Phase 2